Last update 01 Nov 2024

Combretastatin A1 Phosphate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CA1P, Combrestatin A1 diphosphate, Combretastatin A-1 bis(phosphate)
+ [6]
Target
Mechanism
Tubulin modulators
Active Indication
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationRare Pediatric Disease (US), Fast Track (US), Orphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC18H22O12P2
InChIKeyGSOXMQLWUDQTNT-WAYWQWQTSA-N
CAS Registry288847-35-8
View All Structures (2)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatocellular CarcinomaPhase 2--
Acute Myeloid LeukemiaIND Approval
US
01 Oct 2015
Myelodysplastic SyndromesIND Approval
US
01 Oct 2015
Relapsing acute myeloid leukemiaIND Approval
US
01 Oct 2015
Malignant ascitesIND Approval
AU
09 May 2013
Liver CancerIND Approval
AU
02 Apr 2013
Neoplasm MetastasisIND Approval
AU
01 Jul 2009
Advanced Malignant Solid NeoplasmIND Approval
GB
01 Jul 2005
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
26
(uydkkejtln) = kgsywpxfvo tagjfrafca (xrkjvintxg )
Positive
27 Dec 2019
Phase 1
29
(myjatkntnu) = 9.76 mg/m2 ombination with 1 g/m2 ARA-C yhvlxfnaxa (ylsypgpxmm )
Positive
26 Dec 2019
Phase 1/2
26
(vpmmzannpb) = qikdefhioh rmrcfsrcnb (pimqiwvpfd )
Positive
23 Dec 2019
Not Applicable
-
mmaiodbwtq(ueazhlzusp) = extensive areas of necrosis and hemorrhaging compared to untreated controls crxclrnrwz (eqbyjockcm )
-
24 Jul 2012
(Untreated controls)
Phase 1
11
lvdwyqxckm(nwkorbleqe) = showed significant reduction in Ktrans in one patient (0.24mg/m^2) dxqeowfjnx (kkkfiofbas )
-
20 Jun 2007
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free